Related Experiment Video
Updated: Aug 7, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Chemical exposures and Parkinson's disease: a population-based case-control study
Roberta Frigerio1, Kevin R Sanft, Brandon R Grossardt
1Division of Epidemiology, Department of Health Sciences Research, Mayo College of Medicine, Rochester, Minnesota 55905, USA.
Summary
This study suggests pesticide exposure may increase Parkinson's disease (PD) risk in men. Further research is needed to understand potential sex-specific interactions with pesticides.
Area of Science:
- Environmental Health
- Neuroepidemiology
- Toxicology
Background:
- The link between pesticide exposure and Parkinson's disease (PD) is debated.
- Previous studies have yielded inconsistent results regarding this association.
Purpose of the Study:
- To investigate the association between pesticide exposure and the risk of developing Parkinson's disease.
- To explore potential sex differences in the pesticide-PD relationship.
Main Methods:
- Population-based case-control study in Olmsted County, Minnesota (1976-1995).
- Identified 149 Parkinson's disease cases and matched them with 129 general population controls.
- Assessed chemical product exposures, including pesticides, via telephone interviews.
Main Results:
- Pesticide exposure, both farming-related and unrelated, was significantly associated with Parkinson's disease in men (OR, 2.4; 95% CI, 1.1-5.4).
- This association remained significant after adjusting for education and smoking.
- No significant associations were found for other industrial or household chemical exposures.
Conclusions:
- This population-based study indicates a potential link between pesticide use and Parkinson's disease, specifically in men.
- The findings suggest that pesticides may interact with genetic or non-genetic factors that differ between sexes, influencing PD risk.
Related Concept Videos
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...